Felix Lansing (@felix_lansing) 's Twitter Profile
Felix Lansing

@felix_lansing

📍Dresden
🕴️Co-founder and CSO @seamlesstx 🧬Genetics - Genome engineering - Recombinases - Directed evolution 🧬

ID: 1174239641299558400

linkhttps://scholar.google.com/citations?user=3AyTszQAAAAJ&hl=de calendar_today18-09-2019 08:32:17

157 Tweet

149 Followers

202 Following

Sílvia Llonch (@silvia_llonch) 's Twitter Profile Photo

At Conception (conception.bio) we are looking for talented #stemcell scientists! Our goal is to turn stem cells into #human #eggs Interested? DM me and I can provide with more info! #JobAlert #stemcells #reproduction #startup

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

I'd like to take the chance and thank the whole Buchholz Lab. Without the constant support of all lab members we would have not been able to found RecTech. I'm looking forward to continue collaborating with the Buchholz Lab, @Medizin_TUD and TU Dresden!

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Vielen Dank KoerberScience, für die Nominierung meiner Promotionsarbeit für den Deutschen #Studienpreis 2022! Ich freue mich sehr meine Arbeit zu neuartigen Gen Therapien persönlich in Berlin vorstellen zu können. Buchholz Lab @Medizin_TUD TU Dresden

Buchholz Lab (@buchholzlab_tud) 's Twitter Profile Photo

We are happy to attend FASEB's Genome Engineering Conference! We hope everyone enjoyed Frank's talk about the swiss knife of the genome editing tools on Monday. If you want to learn more, check out our posters 16 (Milica Jelicic) and 25 (Liliya Mukhametzyanova) tonight! #GECSRC22 FASEB

We are happy to attend FASEB's Genome Engineering Conference! We hope everyone enjoyed Frank's talk about the swiss knife of the genome editing tools on Monday. If you want to learn more, check out our posters 16 (<a href="/Jacafaca_/">Milica Jelicic</a>) and 25 (<a href="/MLiliya_/">Liliya Mukhametzyanova</a>) tonight!
#GECSRC22 <a href="/FASEBorg/">FASEB</a>
Liliya Mukhametzyanova (@mliliya_) 's Twitter Profile Photo

I’m very happy for having this exciting opportunity to present my work at FASEB‘s Genome Engineering Conference and connect with the great scientists in the field. Very encouraging and motivating! Thank you, FASEB ! #GECSRC22

I’m very happy for having this exciting opportunity to present my work at FASEB‘s Genome Engineering Conference and connect with the great scientists in the field. Very encouraging and motivating! Thank you, <a href="/FASEBorg/">FASEB</a> ! #GECSRC22
Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Ich bin mit Stolz erfüllt unter den diesjährigen Preisträgern und Preisträgerinnen zu sein! Ich danke der Körber Stiftung KoerberScience für diese Auszeichnung! Ich möchte mich auch bei dem Buchholz Lab @Medizin_TUD TU Dresden für die Unterstützung bedanken!

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Congratulations Shady! If you want to learn how base editing can be used to correct two genes frequently mutated in various cancers, don't miss this great paper and tweetorial.

The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS: The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

BREAKING NEWS: 
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”
Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Are you intersted in how recombinases can be potentially used for gene therapy? Then don't miss today's talk from the Buchholz Lab with great results from Liliya Mukhametzyanova. You'll find the details in the program 👇 #ESGCT2022 #bsgct2022 ESGCT BSGCT

Are you intersted in how recombinases can be potentially used for gene therapy? 
Then don't miss today's talk from the <a href="/BuchholzLab_TUD/">Buchholz Lab</a> with great results from <a href="/MLiliya_/">Liliya Mukhametzyanova</a>. You'll find the details in the program 👇 #ESGCT2022 #bsgct2022 <a href="/ESGCT/">ESGCT</a> <a href="/_BSGCT/">BSGCT</a>
Felix Lansing (@felix_lansing) 's Twitter Profile Photo

It was a great pleasure to present work from the Buchholz Lab on designer recombinases at the #ESGCT2022. I'd like to thank the ESGCT for choosing the submitted abstract for a oral presentation and the great audience in yesterday's session.

It was a great pleasure to present work from the <a href="/BuchholzLab_TUD/">Buchholz Lab</a> on designer recombinases at the #ESGCT2022.
I'd like to thank the <a href="/ESGCT/">ESGCT</a> for choosing the submitted abstract for a oral presentation and the great audience in yesterday's session.
Ruslan Rust 🧬🧠 (@rust_ruslan) 's Twitter Profile Photo

New paper🚨 The most important readout in any preclinical #therapy for #stroke⚡️is beahvior. Still, tests in 🐭are poorly reproducible + often unsuitable for unraveling complex recovery. We tried to change that using #DeepLearning, now out BMC Biology bmcbiol.biomedcentral.com/articles/10.11… 🧵.1

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Vielen Dank für die sehr gelungen Preisverleihung. Es war mir eine Ehre den Deutschen Studienpreis der KoerberScience Stiftung von Bärbel Bas persönlich entgegenzunehmen. Danke für diese großartige Auszeichnung für meine Dissertation.

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

It was a great honor receiving this award from the major of Stadt Dresden during yesterday's ceremony. I'd like to thank the whole Buchholz Lab for the years of support to make this possible.

Felix Lansing (@felix_lansing) 's Twitter Profile Photo

Very nice that it's finally out! Congrats Teresa and all others involved 👍👏 Teresa developed a designer recombinase that can excise HTLV-1.

Liliya Mukhametzyanova (@mliliya_) 's Twitter Profile Photo

🎉I am thrilled to announce that my PhD thesis work got published in Nature Biotechnology today! Grateful to all co-authors from Buchholz Lab and @seamlesstx.🧬We developed zinc finger DNA-binding dependent site-specific recombinases. nature.com/articles/s4158… See the thread below: